ERBB2 and cancer: This constitutive phosphorylation of Akt was observed in both HER2-overexpressing and low-expressing cancer cell lines, but significant inhibition of the phosphorylation by gefitinib was observed only in HER2-overexpressing cell lines (Figure 4B).